Bancel Stephane's Form 4 filing
Moderna, Inc. (MRNA) · filed Apr 8, 2022
- Accession no.
- 0001127602-22-011764
- Filed
- Apr 8, 2022
- Trade date
- Apr 6-7, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $2.96M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bancel StephaneCIK 0001443340 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2022 | Common Stock | SSaleDisposed | −5,100 | $158.22F2 | −$806,922 | 5,464,435 | Direct | |
| Apr 6, 2022 | Common Stock | SSaleDisposed | −2,900 | $159.00F3 | −$461,100 | 5,461,535 | Direct | |
| Apr 6, 2022 | Common Stock | SSaleDisposed | −1,000 | $160.27F4 | −$160,270 | 5,460,535 | Direct | |
| Apr 6, 2022 | Common Stock | GGiftDisposed | −4,000 | –F6 | – | 5,456,535 | Direct | |
| Apr 7, 2022 | Common Stock | SSaleDisposed | −10,000 | $153.15 | −$1,531,500 | 6,944,880 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.63 to $158.52. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.75 to $159.75 Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.97 to $160.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The reported disposition represents a bona fide charitable gift made by the reporting person.
Referenced by the price of 1 transaction in Table I.